Khiron Life Sciences (KHRN) Stock Price, News & Analysis

Company Overview

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$0.04 to C$0.05
• 50-Day Range: C$0.04 to C$0.04
• 52-Week Range: C$0.04 to C$0.21
• Volume: 24,000 shs
• Average Volume: 256,268 shs
• Market Capitalization: C$9.30 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KHRN Stock Analysis - Frequently Asked Questions

How have KHRN shares performed this year?

Khiron Life Sciences' stock was trading at C$0.04 at the start of the year. Since then, KHRN shares have increased by 0.0% and is now trading at C$0.04.
View the best growth stocks for 2025 here.

How do I buy shares of Khiron Life Sciences?

Shares of KHRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Khiron Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Khiron Life Sciences investors own include Khiron Life Sciences (KHRNF), Aurora Cannabis (ACB), Alpha Lithium (APHLF), Curaleaf (CURLF), HEXO (HEXO), Intel (INTC) and Neptune Wellness Solutions (NEPT).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: CVE:KHRN
• CIK: N/A
• Web: www.khiron.ca
• Phone: 705-527-3564
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$46.80 million
• Net Margins: -258.92%
• Pretax Margin: N/A
• Return on Equity: -68.62%
• Return on Assets: -20.79%

Debt

• Debt-to-Equity Ratio: 6.68
• Current Ratio: 3.08
• Quick Ratio: 0.72

Sales & Book Value

• Annual Sales: C$18.08 million
• Price / Sales: 0.51
• Cash Flow: C$0.01 per share
• Price / Cash Flow: 6.67
• Book Value: C$0.20 per share
• Price / Book: 0.20

Miscellaneous

• Outstanding Shares: 232,409,000
• Free Float: N/A
• Market Cap: C$9.30 million
• Optionable: Not Optionable
• Beta: 2.64